Dr. Christina Arriens, MD
Claim this profileOklahoma Medical Research Foundation
Studies Systemic Lupus Erythematosus
Studies Lupus
2 reported clinical trials
7 drugs studied
Area of expertise
1Systemic Lupus Erythematosus
ANA positive
dsDNA positive
2Lupus
ANA positive
dsDNA positive
Affiliated Hospitals
Clinical Trials Christina Arriens, MD is currently running
Voclosporin + Mycophenolate Mofetil
for Lupus
The primary purpose of this study is to evaluate the potential effectiveness of 24 weeks of MMF within previously discovered immunologically defined subsets of SLE patients. Treatment effects will be evaluated within the individual immunologically-homogenous subsets defined at screening. This study will also explore and compare pre-randomization gene expression patterns among responders and non-responders to MMF and MMF plus voclosporin, use comprehensive immunophenotyping to study the immunologic changes that accompany treatment- induced disease improvement and to better understand immunologic changes associated with the loss of clinical response.
Recruiting0 awards Phase 21 criteria
Mesenchymal Stem Cells
for Lupus
The purpose of this study is to evaluate the efficacy and safety of mesenchymal stem cells (MSCs) obtained from umbilical cords for the treatment of adults with systemic lupus erythematosus (SLE). The goal of this study is to determine if patients receiving an MSC infusion plus standard of care respond better than patients receiving placebo infusion plus standard of care.
Recruiting0 awards Phase 2
More about Christina Arriens, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christina Arriens, MD has experience with
- High Dose Mesenchymal Stem Cells (MSCs)
- Low Dose Mesenchymal Stem Cells (MSCs)
- Placebo Infusion
- Mycophenolate Mofetil
- Placebo For Mycophenolate Mofetil
- Placebo For Voclosporin
Breakdown of trials Christina Arriens, MD has run
Systemic Lupus Erythematosus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christina Arriens, MD specialize in?
Christina Arriens, MD focuses on Systemic Lupus Erythematosus and Lupus. In particular, much of their work with Systemic Lupus Erythematosus has involved ANA positive patients, or patients who are dsDNA positive.
Is Christina Arriens, MD currently recruiting for clinical trials?
Yes, Christina Arriens, MD is currently recruiting for 2 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Christina Arriens, MD has studied deeply?
Yes, Christina Arriens, MD has studied treatments such as High Dose Mesenchymal Stem Cells (MSCs), Low Dose Mesenchymal Stem Cells (MSCs), Placebo Infusion.
What is the best way to schedule an appointment with Christina Arriens, MD?
Apply for one of the trials that Christina Arriens, MD is conducting.
What is the office address of Christina Arriens, MD?
The office of Christina Arriens, MD is located at: Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the Oklahoma Medical Research Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.